
JAZZ Market Cap & Key Metrics
Jazz Pharmaceuticals plc
$241.55
+$1.18(+0.49%)
63
Overall
60
Value
66
Tech
63
Quality
Market Cap
$15.50B
Volume
496.70K
52W Range
$156.95 - $266.38
Target Price
$296.55
JAZZ market cap is $15.50B. This page lists Jazz Pharmaceuticals plc's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
JAZZ Key Metrics
- Market cap
- $15.50B
- P/E ratio (current-year EPS estimate)
- 21.80
- EPS estimate, current year
- $11.08
- EPS growth, 3-year
- -17.72%
- Value score
- 60
- Quality score
- 63
- Technical score
- 66
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| EBITDA | $263.49M | $1.37B | $1.22B | $535.01M | $718.41M |
| EPS | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JAZZ | $241.55 | +0.5% | 496.70K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Jazz Pharmaceuticals plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW